Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
about
Targeting the molecular and cellular interactions of the bone marrow niche in immunologic diseaseChemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte traffickingActivated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosisCirculating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome.Rapamycin blocks fibrocyte migration and attenuates bronchiolitis obliterans in a murine model.Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model.Fibrocytes and the pathogenesis of diffuse parenchymal lung disease.The role of fibrocytes in fibrotic diseases of the lungs and heartFIZZ2/RELM-β induction and role in pulmonary fibrosisSmall molecule inhibitors of CXCR4.CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in ratsTanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in ratsCirculating fibrocytes are increased in children and young adults with pulmonary hypertension.Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation.Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2Organizing pneumonia in mice and menRegulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitmentCirculating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2.Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.Targeting Neutrophils to Prevent Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome in Mice.Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy.Activation of A2aR attenuates bleomycin-induced pulmonary fibrosis via the SDF-1/CXCR4 axis-related pathway.Kidney injury molecule-1 is involved in the chemotactic migration of mesenchymal stem cells.Mesenchymal stem cells in idiopathic pulmonary fibrosis.Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice.Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis.The emerging role of fibrocytes in ocular disorders.
P2860
Q26865498-1EBD220F-E1C3-4A32-B8C9-C6E30F46860FQ27013008-B49D78F3-53D0-4F8F-B977-A6A33AE2CE9EQ28660307-11A69DB2-D5AA-4A0A-B306-4B5A819BB082Q30362039-41786A36-EEBF-4E5E-8737-F43E855B4707Q30409683-F63C0915-8EA5-49B9-81F5-DC15C2F10F02Q30414598-62C341CA-2FB2-4B9B-A311-4FCA380F5982Q30426516-3EB1CC97-1FF2-423F-9715-EB63D147A73DQ30433418-D23B604B-55DE-403F-9C77-67AF5A95E440Q33648682-3EE43901-6776-41AC-B2F9-DA9C71FB9CDDQ34574987-ED3226E8-B397-4157-9E61-4156EE346769Q35108148-2C5CCBEC-85F6-4AB9-A46E-21B4F45A5476Q35388266-D36B17DA-5B1A-4383-ACE0-A834E6FE935BQ35869442-32FBE4A6-DE5F-46D7-8F1D-AD67F84CF717Q35930523-A99B9E09-C385-4055-9AEF-5E6076340F08Q35964652-437A75C4-5046-49EF-8776-A298CC0A7D3BQ35994457-B033009A-5363-478B-B1CB-A05089EF9F72Q36047448-4B3DBA55-8068-46AE-BC0A-272DF773BDCBQ36539561-15A826CE-4F29-4EEE-B059-07F14FC43A6CQ37087273-95A51B13-B095-4705-9799-C70CC5FFFFE6Q37594827-FC28D794-F181-412B-9010-3CC5A1BB6D47Q37681533-9EEE26C1-46F0-41DE-AB39-B687CD5A8D8BQ38580461-7BF6AE23-446A-4959-886F-E22A852ED1FFQ38963532-E035E3AB-3A37-4FDC-9BD7-69A50C3F5CF6Q39446714-A9725E0E-61EA-4679-9A95-8BF8EDFCDA5FQ40109819-A3D7795A-FCE5-4EFB-A2D1-11A7EAADAD3DQ41640757-61EE2C1D-33A4-462E-9D49-A7867050A144Q42068029-AD94A0CA-27EB-4A14-BC13-D14FCCBCD382Q42230021-345DF2DD-7734-473E-AC6C-EDF823C95431Q47123592-D8F6681C-7F30-441F-92B5-CAC6BFB9B224Q49603082-18D97B88-309A-4A01-B89E-2E7A78436002Q49912722-6A50AD21-B2DF-452A-ADA1-B623F19625FDQ52589503-E3D6CF89-5777-489D-AD21-6E5B475203FB
P2860
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@ast
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@en
type
label
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@ast
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@en
prefLabel
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@ast
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@en
P2093
P2860
P1476
Inhibitory effect of CXC chemo ...... ced murine pulmonary fibrosis.
@en
P2093
Chun Mi Kang
Hwa Sik Moon
Hyeon Hui Kang
Hyung Kyu Yoon
Jeong Sup Song
Kwan Hyung Kim
Sung Hak Park
Young Kyoon Kim
P2860
P2888
P304
P356
10.3858/EMM.2010.42.6.048
P577
2010-06-01T00:00:00Z
P5875
P6179
1026580931